SELECT YEAR: 2011 . 2010 . 2009 . 2008 . 2007 . 2006 . 2005
Chemaphor Inc. Completes Private Placement[+READ] APRIL 27, 2012
Chemaphor Announces Option Grants[+READ] APRIL 19, 2012
Chemaphor Receives First U.S. Order For Oximunol™ Chewables[+READ] APRIL 17, 2012
Chemaphor Pursuing Partnering Initiative to Commercialize Non-antibiotic Feed Additive Alternative to Improve Productivity and Safety in Food-producing Animals[+READ] MARCH 29, 2012
Status Update On Non-Antibiotic OxC-beta Feed Additive[+READ] MARCH 27, 2012
Avivagen Presents Canine Supplement at PEI Home Show[+READ] MARCH 20, 2012
Chemaphor Receives First Approvals For International Feed Additive Patent Application[+READ] FEBRUARY 23, 2012
Avivagen Passes National Animal Supplement Council Certification Audit [+READ] FEBRUARY 15, 2012
Avivagen Announces U.S. Distribution Agreement [+READ] FEBRUARY 10, 2012
Chemaphor Provides Corporate Update [+READ] JANUARY 31, 2012
Chemaphor Inc. Completes Private Placement [+READ] JANUARY 3, 2012
Chemaphor Inc. Announces Correction To Private Placement Disclosure [+READ]
Chemaphor Inc. Completes Private Placement [+READ] DECEMBER 23, 2011
Chemaphor's Avivagen And Vet-stem (USA) Announce Mutual Agreement To Terminate License Agreement [+READ] DECEMBER 13, 2011
Chemaphor Presents to Investor Group at the Richmond Club Webinar [+READ] DECEMBER 6, 2011
Avivagen Exhibits at Winter Woofstock 2011 [+READ] NOVEMBER 30, 2011
Chemaphor Presents Antibiotic Alternative Technology at Canadian Antimicrobial Conference [+READ] NOVEMBER 25, 2011
Chemaphor Inc. Completes Private Placement [+READ] OCTOBER 18, 2011
Avivagen presents at Banff Venture Forum [+READ] OCTOBER 12, 2011
Over 50 more Canadian veterinarians certified to do VetStem RC Regenerative Cell Therapy on companion animals [+READ] SEPTEMBER 28, 2011
Chemaphor Announces Management Change [+READ] SEPTEMBER 28, 2011
Avivagen presents at Agri-Investment Symposium in Vancouver [+READ] AUGUST 9, 2011
Oximunol™ Chewable Tablets draw veterinarians from across Canada to Avivagen Animal Health booth at Canadian Veterinary Medical Association (CVMA) Convention [+READ] JULY 12, 2011
Chemaphor expands companion animal studies program [+READ] JUNE 9, 2011
Non-Antibiotic Product from Chemaphor Inc. Enhances Innate Immunity in Fish [+READ] MAY 27, 2011
Chemaphor Inc. Raises Additional Funds Through Private Placement [+READ] MAY 17, 2011
Island Bioscience Company Launches New Products (press release by PEI Department of Innovation and Advanced Learning) [+READ] MAY 12, 2011
Quebec Veterinarians receptive to new natural supplement for dogs: Oximunol™ Chewable Tablets [+READ] MAY 10, 2011
Former Pfizer Animal Health Executive Joins Avivagen Animal Health [+READ] APR 29, 2011
Chemaphor Inc. Completes First Closing of Private Placement [+READ] APR 26, 2011
Chemaphor Announces Appointment of Jacques Brault as Chairman [+READ] APR 21, 2011
Richmond Investment Club Members learn about leading-edge natural wellness products from Chemaphor Inc.'s Avivagen Animal Health [+READ] APR 19, 2011
Chemaphor Retains the Richmond Club for Investor Relations [+READ] APR 19, 2011
Chemaphor Announces Grant of Options and Issuance of Shares to Directors and Officers in Satisfaction of Debt [+READ] APR 5, 2011
Interest in Oximunol™ Chewable Tablets from Chemaphor's Avivagen Animal Health subsidiary strong at American Animal Hospital Association/Ontario Veterinary Medical Association Conference [+READ] MARCH 31, 2011
Non-antibiotic product from Chemaphor Inc. enhances feed efficiency and growth in food animals [+READ] MARCH 10, 2011
Close to 2000 dogs now on new, natural wellness product: Oximunol™ Chewable Tablets from Avivagen Animal Health Inc. [+READ] MARCH 4, 2011
Interest in Oximunol™ Chewable Tablets strong at Ontario Association of Veterinary Technicians Conference [+READ] FEBRUARY 24, 2011
Over 100 Canadian veterinarians now certified to do VetStem RC Regenerative Cell Therapy on companion animals [+READ] JANUARY 6, 2011
Chemaphor Inc. Issues Shares in Satisfaction of Principal and Interest [+READ]
Chemaphor Inc. Raises $80,000 in Private Placement [+READ] NOVEMBER 25, 2010
Chemaphor Inc. Raises $192,000 in Private Placement [+READ] NOVEMBER 18, 2010
Chemaphor Announces Official Launch of Avivagen Animal Health Inc. [+READ] NOVEMBER 5, 2010
Chemaphor Readies Commercial Launch of Companion Animal Health Products and Services and Announces Management and Board Changes [+READ] OCTOBER 29, 2010
Chemaphor Inc. Raises $184,500 in Private Placement [+READ] OCTOBER 7, 2010
Chemaphor Inc. Raises $180,000 in Private Placement [+READ] OCTOBER 1, 2010
Chemaphor Announces Corporate and Management Changes in Preparation for Commercial Launch of Companion Animal Health Products and Services [+READ] SEPTEMBER 7, 2010
Chemaphor Inc. Raises Funds in Private Placement [+READ] JULY 7, 2010
Chemaphor Issues Shares in Satisfaction of Interest [+READ] JUNE 28, 2010
Chemaphor Announces OximunolTM Chewables Commercialization Plan [+READ] JUNE 23, 2010
Chemaphor gets Commercial, Healthcare and Animal Health Experience Boost: Amin Khalifa Joins the Board as Co-Chair [+READ] JUNE 21, 2010
Chemaphor Launches into Stem Cell Therapy Market in Canada Through Acquisition [+READ] JUNE 14, 2010
Chemaphor Announces Oximunol™ Chewables Development Update [+READ] FEBRUARY 1, 2010
Chemaphor Announces Positive Results of Pilot Canine Clinical Trial of an OximunolTM Supplement [+READ] JANUARY 27, 2010
Chemaphor Project Chosen to Receive a Share of Government of Canada Investment in R&D to Drive Growth in Atlantic Canada [+READ] JANUARY 6, 2010
Chemaphor Issues Shares in Satisfaction of Interest [+READ]
November 11 2009 Chemaphor Raises Additional Funds in Private Placement [+READ] OCTOBER 23, 2009
Chemaphor Raises Funds in Private Placement [+READ] SEPTEMBER 28, 2009
Chemaphor Intends to Complete Private Placement [+READ] SEPTEMBER 2009
BIOTECanada Chemaphor Article: Animal Immune System get a Boost from Biotechnology [+READ] AUGUST 24, 2009
Chemaphor Announces a Second Contribution Agreement with NRC-IRAP [+READ] AUGUST 19, 2009
Chemaphor and NRC-INH Receive Funding Support for Joint Research from PEI Government [+READ] AUGUST 12, 2009
Chemaphor Announces Formation of Expert Business and Technology Advisory Team [+READ] AUGUST 10, 2009
Chemaphor Developing a Food Animal and Companion Animal Product Platform [+READ] AUGUST 6, 2009
Chemaphor and Elanco End Relationship [+READ] JULY 23, 2009
NRC-IRAP Announces Contribution to Chemaphor[+READ] JUNE 22, 2009
Chemaphor Announces Agreement with Allied Biotech Corporation [+READ] APRIL 30, 2009
Chemaphor Completes Private Placement [+READ] APRIL 20, 2009
Chemaphor Announces Option Grants [+READ] APRIL 9, 2009
Chemaphor Announces a Contribution Agreement with NRC-IRAP [+READ] MARCH 2, 2009
Chemaphor Announces Launch of Specialty Chemicals Business [+READ] FEBRUARY 24, 2009
Chemaphor Provides Business Update, Financial Results, and Status of Private Placement [+READ]
Chemaphor Announces Proposed Private Placement[+READ] SEPTEMBER 30, 2008
Chemaphor Announces Appointment of Dr. Paul Dick as Director [+READ] SEPTEMBER 10, 2008
Chemaphor Appoints Dr. Paul Dick as Chief Executive Officer [+READ] JULY 23, 2008
Chemaphor Announces Option Grants[+READ] APRIL 24, 2008
Election of New Director [+READ]
Elanco Exercises Commercial Rights [+READ] SEPTEMBER 12, 2007
Chemaphor Receives Intial Proceeds under OxBC Research with Elanco [+READ] MAY 28, 2007
Chemaphor Receives National Biotechnology Award For Promising Early Stage Company [+READ] APRIL 25, 2007
Updates on Business at Annual General Meeting [+READ] MARCH 27, 2007
Q1/2007 Financial Results [+READ] FEBRUARY 28, 2007
Financial Results for Year Ended October 31 2006[+READ] FEBRUARY 2, 2007
Christopher Newman appointed to Scientific Advisory Board and Mark Goudie as Director [+READ] JANUARY 12, 2007
Chemaphor Announces Proposed Private Placement Terms [+READ]
Chemaphor Reaches Commercialization Agreement with Elanco [+READ] SEPTEMBER 29, 2006
Corporate Update and Q3 Results [+READ] AUGUST 24, 2006
Chemaphor Reaches Agreement with Atlantic Canada Opportunities Agency [+READ] JUNE 15, 2006
Positive Results for Feed Additives in Animals [+READ] MAY 2, 2006
Chief Financial Operator Appointed Correction [+READ] MAY 2, 2006
Chief Financial Operator Appointed [+READ] MARCH 31, 2006
Chemaphor to be Offered $2.1 Million Contribution by Atlantic Canada Opportunities Agency [+READ]
Chemaphor Retains Evoloution Group Inc. to assist with its Financial Communication Program [+READ] AUGUST 5, 2005
Successful Amalgamation Chemaphor begins Trading Today [+READ]